Invitrogen Corporation

(NASDAQ:IVGN)

24.51

-0.78 (-3.08%)

Jan 07 - Close

Open
24.26
High
25.34
Low
24.20
Vol.
2.74M
Mkt Cap
2.34B
52Wk High
49.00
52Wk Low
19.56
Avg. Vol.
1.77M
P/E (Trailing)
13.39
Beta
0.00
Short %
18.70%
Div. Yield
—

After-Hours 24.51 0.00 (0.00%) Wed, 7 Jan 2009 7:40 PM

Company Profile

Invitrogen Corporation

5791 Van Allen Way

Carlsbad, CA 92008

United States - Map

Phone: (760) 603-7200

Fax: (760) 602-6500

Website: www.invitrogen.com

State of incorporation: Delaware

CEO: Gregory T. Lucier

Employees: 4,300

Sector: Healthcare

Industry Group: Drugs

Industry: Biotechnology

Biological products.

A developer, manufacturer and marketer of research tools in reagent, kit and high-throughput applications forms to customers engaged in life sciences research, drug discovery, diagnostics and the commercial manufacture of biological product

Recent news for IVGN

Members owning IVGN also own

QCOM (20.00%), EPD (20.00%), NRG (20.00%), STRA (20.00%), FLR (20.00%)

Member sentiment (?)    Neutral

- MarketGuru Blog network-

Top members owning IVGN

* Average monthly return vs. S&P 500

Recent opinions on IVGN

No recent Opinions for IVGN